Cargando…
Essential complicity of perforin-granzyme and FAS-L mechanisms to achieve tumor rejection following treatment with anti-CD137 mAb
BACKGROUND: Treatment with agonist anti-CD137 (4-1BB) immunostimulatory monoclonal antibodies elicits complete tumor regressions in a number of transplanted hematological and solid malignancies in mice. Rejection is mainly dependent on cytotoxic T lymphocytes (CTL) and IFNγ, although a role for NK c...
Autores principales: | Morales-Kastresana, Aizea, Catalán, Elena, Hervás-Stubbs, Sandra, Palazón, Asis, Azpilikueta, Arantza, Bolaños, Elixabet, Anel, Alberto, Pardo, Julián, Melero, Ignacio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987045/ https://www.ncbi.nlm.nih.gov/pubmed/24764534 http://dx.doi.org/10.1186/2051-1426-1-3 |
Ejemplares similares
-
Therapeutic activity of a combination of immunostimulatory monoclonal antibodies (anti-B7-H1, CD137 and OX40) on a c-myc-driven spontaneous transgenic model of hepatocellular carcinoma
por: Morales-Kastresana, Aizea, et al.
Publicado: (2013) -
Hypoxia-induced soluble CD137 in malignant cells blocks CD137L-costimulation as an immune escape mechanism
por: Labiano, Sara, et al.
Publicado: (2014) -
Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb
por: Bolaños-Mateo, Elixabet, et al.
Publicado: (2014) -
Dendritic Cells Take up and Present Antigens from Viable and Apoptotic Polymorphonuclear Leukocytes
por: Alfaro, Carlos, et al.
Publicado: (2011) -
Perforin, granzyme B, and FasL expression by peripheral blood T lymphocytes in emphysema
por: Morissette, Mathieu C, et al.
Publicado: (2007)